Back to companies
4D Molecular Therapeutics, Inc.
FDMTUSNASDAQPharmaceuticals & Healthcare4D Molecular Therapeutics, Inc.
Revenue
$85.2mn
YoY +230194.6%
Operating income
-$159.5mn
FY2025
Employees
—
Founded
—
Source: U.S. Securities and Exchange Commission (SEC) EDGAR Company Facts API